A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Morris, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
72 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital de Amor de Barretos (fundação Pio Xii) / Barretos Cancer Hospital
Barretos, Dr. Paulo Prata, Brazil
- Instituto de Medicina Integral Professor Fernando Figueira (imip)
Boa Vista, Pernambuco, Brazil
- Instituto Brasileiro de Controle Do Câncer/ibcc
São Paulo, State of São Paulo, Brazil
- Hospital Sírio Libanês
Brasília, Brazil
- Hospital Erasto Gaertner
Curitiba, Brazil
- Cpors - Centro de Pesquisa Em Oncologia Do Hospital São Lucas Da Pucrs
Porto Alegre, Brazil
- Hospital Moinhos de Vento (hmv)
Porto Alegre, Brazil
- Beneficência Portuguesa
São Paulo, Brazil
- Centro de Pesquisas São Lucas - Sociedade Campineira de Educação E Instrução (scei)
São Paulo, Brazil
- Hospital Israelita Albert Einstein
São Paulo, Brazil
- Nederlands Kanker Instituut
Amsterdam, Plesmanlaan, Netherlands
- Noordwest Ziekenhuisgrouep Alkmaar (nwz)
Alkmaar, Netherlands
- Ziekenhuisgroep Twente (zgt)
Almelo, Netherlands
- Amphia Hospital
Breda, Netherlands
- Deventer Ziekenhuis
Deventer, Netherlands
- Tergooi Hospital
Hilversum, Netherlands
- Canisius Wilhelmina Ziekenhuis (cwz)
Nijmegen, Netherlands
- Erasmus Mc Cancer Institute
Rotterdam, Netherlands
- Franciscus Gasthuis & Vlietland
Rotterdam, Netherlands
- Maasstad Hospital
Rotterdam, Netherlands
- Haaglanden Medical Center
The Hague, Netherlands
- St. Antonius Ziekenhuis (utrecht)
Utrecht, Netherlands
- Isala Kliniek
Zwolle, Netherlands
- Hospital Universitario Central de Asturias (huca)
Oviedo, Avenida de Roma S/n, Spain
- Ramón Y Cajal Hospital
Madrid, Madrid, Spain
- Clinic de Barcelona
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- Vall D'Hebron Institute of Oncology (vhio)
Barcelona, Spain
- Hospital Provincial de Castellón
Castellon, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Virgen del Rocío
Seville, Spain
- Instituto Valenciano de Oncología
Valencia, Spain
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Yale University- Yale Cancer Center
New Haven, Connecticut, United States
- Helen Graham Cancer Center (christiana Care)
Newark, Delaware, United States
- Boca Raton Regional Hospital
Boca Raton, Florida, United States
- Mount Sinai Medical Center (miami)
Miami, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- Ochsner Cancer Institute
New Orleans, Louisiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Jun 2018
- Primary completion
- 1 Apr 2027
- Completion
- 1 Apr 2027
- Last update posted
- 14 May 2026
- Registered enrollment
- 732
- Registry id
- NCT03574571
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.